Skip to main content

COVID-19 Technologies

ORNL Intellectual Property for the COVID-19 Pandemic

Across the United States, businesses of all sizes are working to find solutions to the COVID-19 pandemic. To support these efforts, Oak Ridge National Laboratory (ORNL) is making a portfolio of COVID-19 Related Technologies available for licensing at no cost under its COVID-19 Rapid Access Licensing Program. The goal of this program is to provide industry partners with access to ORNL innovations as quickly and seamlessly as possible during this public health crisis.

COVID-19 Rapid Access Licensing Program


Eligible licensees: Any US entity, company, or university
Eligible intellectual property: Any technologies on this list not otherwise subject to a contractual obligation
License term:  1 year
Royalties:  zero
Negotiations:  zero
Rights:  Nonexclusive

How to Participate

  1. Search for technologies in the COVID-19 Rapid Access Licensing Program.
  2. Download, fill out, and sign the COVID-19 Rapid Access License.
  3. Email your application and license to

For more information, contact us at

Please note: COVID-19 Rapid Access Licenses do not include technical support. For information regarding funding opportunities for technical support, please visit ORNL’s Technology Transfer Webpage.